JP-1302: A new tool to shed light on the roles of α 2C- adrenoceptors in brain

British Journal of Pharmacology

Volumn 150, Issue 4, 2007, Pages 381-382

  Tricklebank, M D ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

2B; 2 adrenoceptors; 2A; 2C adrenoceptor antagonists; Behaviour; Depression; Psychosis

Indexed keywords

ALPHA 2C ADRENERGIC RECEPTOR; JP 1302; UNCLASSIFIED DRUG;

BRAIN; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ACRIDINES; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; ANIMALS, GENETICALLY MODIFIED; BRAIN CHEMISTRY; MICE; PIPERAZINES; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA-2;

EID: 33847170307     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0707007     Document Type: Review

References (13)

1. Alexander SPH, Mathie A, Peters JA (2006). Guide to receptors and channels. Br J Pharmacol 147 (Suppl 3): S12.
2. Bjorklund M, Sirvio J, Sallinen J, Scheinin M, Kobilka BK, Riekkinen Jr P (1999). Alpha2C-adrenoceptor overexpression disrupts execution of spatial and non-spatial search patterns. Neuroscience 88: 1187-1198.
3. Bucheler MM, Hadamek K, Hein L. (2002). Two alpha(2)-adrenergic receptor subtypes, alpha(2A) and alpha(2C), inhibit transmitter release in the brain of gene-targeted mice. Neuroscience 109: 819-826.
4. Kable JW, Murrin LC, Bylund DB (2000). In vivo gene modification elucidates subtype-specific functions of alpha(2)-adrenergic receptors. J Pharmacol Exp Ther 293: 1-7.
5. Kalkman HO, Neumann V, Hoyer D, Tricklebank MD (1998). The role of alpha2-adrenoceptor antagonism in the anti-cataleptic properties of the atypical neuroleptic agent, clozapine, in the rat. Br J Pharmacol 124: 1550-1556.
6. Kleven MS, Assie MB, Cosi C, Barret-Grevoz C, Newman-Tancredi A (2005). Anticataleptic properties of alpha2 adrenergic antagonists in the crossed leg position and bar tests: differential mediation by 5-HT1A receptor activation. Psychopharmacology (Berlin) 177: 373-380.
7. Makaritsis KP, Handy DE, Johns C, Kobilka B, Gavras I, Gavras H (1999). Role of the alpha2B-adrenergic receptor in the development of salt-induced hypertension. Hypertension 33: 14-17.
8. 2C-adrenoceptor antagonist JP-1302. Br J Pharmacol 150: 391-402 (this issue).
9. Sallinen J, Haapalinna A, MacDonald E, Viitamaa T, Lahdesmaki J, Rybnikova E et al. (1999). Genetic alteration of the alpha2-adrenoceptor subtype c in mice affects the development of behavioral despair and stress-induced increases in plasma corticosterone levels. Mol Psychiatry 4: 443-452.
10. Sallinen J, Haapalinna A, Viitamaa T, Kobilka BK, Scheinin M (1998a). Adrenergic alpha2C-receptors modulate the acoustic startle reflex, prepulse inhibition, and aggression in mice. J Neurosci 18: 3035-3042.
11. Sallinen J, Haapalinna A, Viitamaa T, Kobilka BK, Scheinin M (1998b). -amphetamine and L-5-hydroxytryptophan-induced behaviours in mice with genetically-altered expression of the alpha2C-adrenergic receptor subtype. Neuroscience 86: 959-965.
12. Sun B, Lockyer S, Li J, Chen R, Yoshitake M, Kambayashi JI (2001). OPC-28326, a selective femoral vasodilator, is an alpha2C-adrenoceptor-selective antagonist. J Pharmacol Exp Ther 299: 652-658.
13. Zhang W, Ordway GA (2003). The alpha2C-adrenoceptor modulates GABA release in mouse striatum. Brain Res Mol Brain Res 112: 24-32.